Feature | Cardiac Imaging | March 17, 2019| By Greg Freiherr

Mixed Reality Offers Advantages of Virtual and Augmented Realities for Cardiology

Hybrid Mixes Digital Data With Natural Environment

Jennifer N. A. Silva, M.D., a pediatric cardiologist at Washington University School of Medicine in Saint Louis, Mo., describes “mixed reality” at ACC19 Future Hub.

Jennifer N. A. Silva, M.D., a pediatric cardiologist at Washington University School of Medicine in Saint Louis, Mo., describes “mixed reality” at ACC19 Future Hub.

Greg Freiherr

Jennifer N. A. Silva, M.D., a pediatric cardiologist at Washington University School of Medicine in Saint Louis, Mo., describes “mixed reality” at ACC19 Future Hub.

Virtual reality (VR) and its less immersive kin, augmented reality (AR), are gaining traction in some medical applications. But a new entrant, “mixed reality,” may have the inside track in the interventional suite or operating room.

Mixed reality allows the user to interact with both the real world and digital data, according to Jennifer N. A. Silva, M.D., a pediatric cardiologist at Washington University School of Medicine in Saint Louis, Mo., who spoke during Future Hub at the 2019 American College of Cardiology (ACC) annual meeting (#ACC19).

With ready access to both digital and physical reality, a surgeon or interventionalist can simulate a procedure on a digitally created model that is updated in real time – then perform the actual procedure on the patient.

“Mixed reality affords the ability to remain in your natural environment,” Silva told Diagnostic and Interventional Cardiology (DAIC). Yet the users of mixed reality can take advantage of a digital world otherwise found only in VR.

Mixed reality is somewhere in the middle of what Silva described as a spectrum of “extended realities.” At one end is virtual reality (VR), which completely immerses the user in a digital world. Because VR is a completely separate and alternative reality, it “does not allow you to have a meaningful interaction with your natural environment,” she said.

At the other end of the spectrum is reality, characterized by what we sense with our eyes.  In between these two ends are augmented reality (to which mixed reality is closely related). In AR, the user cannot interact with but rather only look at digital data imported into the natural environment, Silva said.

“Mixed reality allows you to have a meaningful interaction with digital data and with your natural environment,” she said. “So instead of just looking at a hologram, you can do something to it -- you can touch it; rotate it; turn it upside down.”

 

Fitting Round Pegs Into Round Holes

The technology – and the type of reality it harnesses – “has to fit what you are trying to do,” she told ITN and DAIC. “There has to be a match between the technology and the need.”

Different types of reality may be useful in one or more of the four major application areas: education, pre-procedural planning, rehabilitation and intraprocedural visualization. VR offers little value during procedures, because it immerses the user in a completely digital world and, therefore, blocks out the natural environment. For this same reason, however, VR may be useful in rehabilitation, as it may replace the user’s perception of the real world with a digital one.

VR may also be useful when practicing a surgical or interventional procedure. Augmented reality has proven useful in actual interventions, presenting data that a surgeon or interventionalist can use during the actual procedure. But mixed reality offers the ability to interact with digital data and with the real world in the same context and time frame.

“If I’m doing a procedure, I can’t fully remove myself from that environment (to interact in VR). I need something that will allow me to interact with my natural environment and with the digital data,” said Silva, who was one of the moderators during March 16 ACC Future Hub session titled “Are Clinical Virtual Reality and Augmented Reality Ready for Prime Time?”

“The ability to manipulate and control your data is perhaps the single greatest value add of the extended realities,” she told ITN and DAIC. Theoretically, mixed reality allows this manipulation and control.

“We are on the first step of what I think will be a long road,” said Silva, who is one of the founders of a mixed reality company, called SentiAR.

Silva and her colleagues right now are struggling to achieve connectivity among the different pieces of equipment found in an EP interventional lab. Examples of this equipment are fluoroscopy systems, vital signs monitors and cardiac mapping systems. “A lot of them are made by different vendors, so it lends itself to poor interoperability,” she said. The goal is to integrate the data from the equipment, as well as their workflows.

“I want to make the platform the glue that starts to allow me to interact with all my pieces of equipment,” she said. 

 

How Mixed Reality Might Impact EP

Mixed reality may prove particularly useful during electrophysiological procedures, when interventionalists map electrical activity inside the patient’s heart, then ablate tissues associated with electrical signals that cause arrhythmia. The device being developed by SentiAR creates a 3-D model of the patient’s heart that shows the map of electrical signals in real-time, said Silva who specializes in pediatric cardiology. The mixed reality platform being developed at SentiAR can be used on patients of any age, she noted.

The user can see 3-D images and other digital data, as well as the physical world, by looking through a head-mounted technology called HoloLens, which is made by Microsoft.  Silva described it as “a computer on your head” that allows the user to see digitally created structures superimposed on a view of the natural environment.  Simultaneously, sensors built into the head-mounted technology record head movements that allow the user to click through digital menus projected onto the user’s field of vision or to control different pieces of equipment in the interventional lab.

Although HoloLens has proven useful, the company is not inextricably tied to the Microsoft technology. Instead, the SentiAR is keeping its options open to take advantage of new technologies that may come along. “There are many mixed reality headsets out there, and there are many more in development,” she said. 

Silva said the product being developed by SentiAR is a long way from finalization. “As good technology does, it will continue to evolve,” she said, noting that future technologies may harness new types of reality that represent different points on the “extended realities” spectrum.

“This (spectrum) is where innovation is going to happen.”

 

Greg Freiherr is a contributing editor to Imaging Technology News (ITN). Over the past three decades, Freiherr has served as business and technology editor for publications in medical imaging, as well as consulted for vendors, professional organizations, academia, and financial institutions.

 

Additional Content:

Two Technologies That Offer a Paradigm Shift in Medicine at HIMSS 2017 

VIDEO: Augmented Reality for Surgical Planning

VIDEO: Users Can Touch This Virtual Reality Heart

A 40,000 Foot View of Trends in Cardiology

Applications for Artificial Intelligence in Cardiovascular Imaging

Machine Learning Approaches in Cardiovascular Imaging

Technology Report: Artificial Intelligence (Video report published January 2019) 

PODCAST: Shortcomings of CTA in Cardiology

PODCAST: How Technology Is Changing Cardiology

ACC.19 Future Hub Hosts “Shark Tank” of Emerging Technologies In Cardiology

 

Related Content

SyncVision iFR Co-registration from Philips Healthcare maps pressure readings onto angiogram. Results from an international study presented at ACC 2019 indicates pressure readings obtained using iFR (instantaneous wave-free ratio, also referred to as instant wave-free ratio or instant flow reserve) in coronary arteries may localize stenoses that remain after interventions. FFR in the cath lab.

SyncVision iFR Co-registration from Philips Healthcare maps pressure readings onto angiogram. Results from an international study presented at ACC 2019 indicates pressure readings obtained using iFR (instantaneous wave-free ratio, also referred to as instant wave-free ratio or instant flow reserve) in coronary arteries may localize stenoses that remain after interventions.

Feature | ACC | March 27, 2019 | Greg Freiherr, Contributing Editor
The fingerprints of value-added medicine were all over products and works-in-progress on the exhibit floor of the a

The opening late-breaking trial at ACC 2019 is the Apple Heart Study, a large-scale, app-based study to identify atrial fibrillation using a smartwatch. Earlier, smaller trials showed this approach might be used in a population health application to proactively identify AFib patients earlier.

Feature | ACC | March 19, 2019
The American College of Cardiology (ACC) released a list of the late
A patient who received HeartMate III LVAD system at ACC.18. The HeartMate 3 was the topic of of the the key late-breaking trials at #ACC18

A patient who received the HeartMate III LVAD system showing off his external battery pack. He served as a patient ambassador in the Abbott booth at ACC.18. The HeartMate III, with its magnetic levitated pump, showed a big reduction in clotting over previous LVADs in a key late-breaking trial at this year's conference.

Feature | ACC | March 27, 2018 | Dave Fornell
There were several notable presentations of new data on cardiovascular technologies at the recent 2018 American Colle
Drug Stops Dangerous Bleeding in Patients Taking Factor Xa Inhibitors

Connolly 

News | ACC | March 22, 2018
March 22, 2018 — The experimental drug...
Videos | ACC | March 21, 2018
DAIC Editor Dave Fornell takes a tour of some of the most interesting new technologies on the expo floor at
ACC 2018 Late-Breaking Trials Announced
News | ACC | March 21, 2018
Here is a list of the American College of Cardiology (ACC) 2018 annual meeting late-breaking clinical trials presente
Inhaled Therapy Ineffective in Difficult-to-Treat Heart Failure at ACC 2018.

Image from presentation, "Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF: The INDIE-HFpEF Trial," Borlaug

News | ACC | March 20, 2018
March 20, 2018 — Four weeks of treatment with a novel inhaled medication failed to improve exercise capacity, daily a
More Deaths, Strokes Seen with Perioperative Beta Blocker One Year After Surgery

Image from presentation, "1-Year outcomes of perioperative beta-blockade in patients undergoing noncardiac surgery," Devereaux 

News | ACC | March 20, 2018
March 20, 2018 — During the 12 months after undergoing noncardiac surgery, patients with or at risk for heart disease
Trial for Gout Drug Meets Primary Endpoint, Raises Safety Concerns, image shows a CT scan showing gout in the knees.
News | ACC | March 20, 2018
March 20, 2018 — Febuxostat, a gout dr...
Canakinumab Doesn’t Prevent Prediabetes from Progressing to Diabetes according to a late-breaking study at ACC 2018.
News | ACC | March 20, 2018
March 20, 2018 — The anti-inflammatory...
Overlay Init